首页> 美国卫生研究院文献>Dentistry Journal >The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
【2h】

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients

机译:血液学师和牙医之间联盟的重要性:一种回顾性研究对多发性骨髓瘤患者颌骨(Bronj)的Bisphones oS one oSteoncross的开发研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(1) Background: Multiple myeloma is a rare cancer that primarily affects the bone marrow. Osteoclasts are responsible for increased bone resorption and, therefore, bone destruction. Bisphosphonates are a class of drugs that can slow down bone resorption by reducing the number and action of osteoclasts. Intravenous injections of bisphosphonates (generally Zoledronic Acid) are administered to patients affected by Multiple Myeloma, but BRONJ is described as a serious side effect. This 5-year retrospective study aims to evaluate the efficacy of appropriate dental treatment protocols prior to initiating bisphosphonate therapy to prevent the development of BRONJ. (2) Methods: A total of 99 patients with symptomatic multiple myeloma were involved in this study (41–90 years, mean age 65 years, standard deviation 5 years). The data relating to the visits were tracked using a specific server and consulting the clinical reports. The AAOMS (American Association of Oral and Maxillofacial Surgeons) position was applied for both diagnosis and treatment. A total of 79 patients were examined before the administration of bisphosphonates (group A) and 20 after (group B). (3) Results: The entire sample required dental treatment: 23.2% underwent restorative therapy, 8% endodontic treatments, 44.4% tooth extractions. Periodontal disease was present in 41.4% of the patients. No osteonecrosis was observed in the first group, whereas BRONJ was found in five patients of the second one (25%) and two patients (10%) showed osteosclerotic areas under investigation [OR 0.026 (CI 0.0027 to 0.2454)]. (4) Conclusions: In the literature, there are no precise data about the prevalence of BRONJ. Despite the limitation of the present study, we point out that dental treatment before the treatment with intravenous bisphosphonates can help in reducing the incidence of BRONJ and good dental status is necessary for BRONJ prevention.
机译:(1)背景:多发性骨髓瘤是一种罕见的癌症,主要影响骨髓。破骨细胞负责骨吸收增加,因此骨破坏。双膦酸盐是一类药物,可以通过减少破骨细胞的数量和作用来减缓骨吸收。静脉注射双膦酸盐(一般唑膦酸)被施用于受多种骨髓瘤影响的患者,但Bronj被描述为严重的副作用。该5年的回顾性研究旨在在启动双膦酸盐治疗之前评估适当牙科治疗方案的疗效,以防止Bronj的发育。 (2)方法:本研究共有99例患有症状多发性骨髓瘤患者(41-90岁,平均65岁,标准偏差5年)。使用特定服务器跟踪与访问有关的数据,并使用特定服务器进行咨询报告。 AAOMS(美国口腔颌面外科医生)的诊断和治疗施用。在施用双膦酸盐(A组)和20后,共检查总共79名患者(B组)。 (3)结果:整个样品所需的牙科治疗:23.2%接受恢复治疗,8%的胸腔处理,牙齿提取物44.4%。牙周病存在于41.4%的患者中。在第一组中未观察到骨折,而Bronj发现在第二款(25%)和两名患者(10%)的患者中发现,在调查中显示出骨髓性区域[或0.026(CI 0.0027至0.2454)]。 (4)结论:在文献中,有关Bronj的患病率没有精确的数据。尽管对本研究的限制,但我们指出牙科治疗前的静脉内双膦酸盐可以有助于降低支架的发生率,并且需要良好的牙科状态对于Bronj预防是必要的。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号